THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 89 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,276,000 | +603.3% | 577,800 | +1450.8% | 0.40% | +35.7% |
| Q2 2019 | $608,000 | -89.3% | 37,258 | -92.8% | 0.30% | -69.0% |
| Q3 2015 | $5,680,000 | -10.6% | 516,804 | +5.9% | 0.96% | +8.4% |
| Q2 2015 | $6,354,000 | +50.3% | 487,992 | +100.2% | 0.88% | +39.7% |
| Q1 2015 | $4,228,000 | +13.1% | 243,706 | -2.7% | 0.63% | +9.1% |
| Q4 2014 | $3,738,000 | – | 250,550 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chescapmanager LLC | 1,134,718 | $23,160,000 | 2.47% |
| Baupost Group | 8,735,168 | $178,285,000 | 1.42% |
| Orbimed Advisors | 6,219,110 | $126,932,000 | 1.19% |
| CM Management, LLC | 50,000 | $1,021,000 | 0.76% |
| Tekla Capital Management LLC | 456,296 | $9,313,000 | 0.32% |
| Rock Springs Capital Management LP | 682,600 | $13,932,000 | 0.30% |
| Virtus ETF Advisers LLC | 32,871 | $671,000 | 0.28% |
| Cormorant Asset Management, LP | 550,000 | $11,226,000 | 0.25% |
| DAFNA Capital Management LLC | 41,165 | $840,000 | 0.20% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 484,206 | $9,883,000 | 0.18% |